Judi R. Lum

Health Technology

Consumer Services

Profile

Ms. Lum is Chief Financial Officer and VP of Finance.
She previously served as Chief Financial Officer of Inhale Therapeutic Systems (currently Nektar Therapeutics) where she was responsible for the accounting (including planning, tax, treasury and SEC reporting), human resources and IT functions.
At Inhale she participated in raising $75 million in public and private equity and established $15 million in debt financing.
Prior to Inhale she served as Chief Financial Officer at Soane Technologies, Director of Corporate Development at GenPharm International, Director of Finance at Raychem Corporation, and in finance and operations management capacities at Advanced Cardiovascular Systems.
Ms. Lum received both her Bachelor's Degree in Economics and her Master's Degree in Business Administration from Stanford University.

Former positions of Judi R. Lum

Companies	Position	End
StemCells, Inc. StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA.	Director of Finance/CFO	06/09/2005

See the detail of Judi R. Lum's experience

Training of Judi R. Lum

Stanford University

Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies